The role of CD95 and CD95 ligand in cancer (vol 22, pg 885, 2015)

被引：62

作者：

Peter, M. E.

Hadji, A.

Murmann, A. E.

Brockway, S.

Putzbach, W.

Pattanayak, A.

Ceppi, P.

机构：

来源：

CELL DEATH AND DIFFERENTIATION | 2015年 / 22卷 / 05期

关键词：

D O I：

10.1038/cdd.2015.25

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Correction to: Cell Death and Differentiation (2015) 22, 549–559; doi:10.1038/cdd.2015.3; published online 6 February 2015 Since the publication of this article the authors have noted that they have inadvertently failed to list an important paper in the field in Table 2. This work (Kleber et al.) has now been added to the revised Table 2 shown below.

引用

页码：885 / 886

页数：2

共 50 条

[21] Mycobacterium tuberculosis exploits the CD95/CD95 ligand system of γδ T cells to cause apoptosis
Manfredi, AA
Heltai, S
Rovere, P
Sciorati, C
Paolucci, C
Gelati, G
Rugarli, C
Vaiani, R
Clementi, E
Ferrarini, M
EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (06) : 1798 - 1806
[22] Differences between CD95 type I and type II cells detected with the CD95 ligand
Schmitz, I
Walczak, H
Krammer, PH
Peter, ME
CELL DEATH AND DIFFERENTIATION, 1999, 6 (09): : 821 - 822
[23] CD95-tyrosine nitration inhibits hyperosmotic and CD95 ligand-induced CD95 activation in rat hepatocytes
Reinehr, R
Görg, B
Höngen, A
Häussinger, D
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (11) : 10364 - 10373
[24] The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis
Manlio Tolomeo
Luisa Dusonchet
Maria Meli
Stefania Grimaudo
Natale D'Alessandro
Giuliana Papoff
Giovina Ruberti
Luciano Rausa
Cell Death & Differentiation, 1998, 5 : 735 - 742
[25] The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis
Tolomeo, M
Dusonchet, L
Meli, M
Grimaudo, S
D'Alessandro, N
Papoff, G
Ruberti, G
Rausa, L
CELL DEATH AND DIFFERENTIATION, 1998, 5 (09): : 735 - 742
[26] Evaluation of CD95 (APO-1/FAS) and the CD95 ligand in acute myelogenous leukemia
Mestice, A
Specchia, G
Coppi, MR
Palumbo, G
Carluccio, P
Attolico, I
Quarta, A
Liso, V
EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 74 - 74
[27] Dysregulation of CD95/CD95 ligand apoptotic pathway in CD3+ large granular lymphocyte leukemia
Lamy, T
Liu, JH
Landowski, TH
Dalton, WS
Loughran, TP
BLOOD, 1998, 92 (12) : 4771 - 4777
[28] CD95/CD95L interactions and their role in autoimmunity
L. Ricci-Vitiani
C. Conticello
A. Zeuner
R. De Maria
Apoptosis, 2000, 5 : 419 - 424
[29] CD95/CD95L interactions and their role in autoimmunity
Ricci-Vitiani, L
Conticello, C
Zeuner, A
De Maria, R
APOPTOSIS, 2000, 5 (05) : 419 - 424
[30] The role of CD95 system in chemotherapy
Debatin, KM
DRUG RESISTANCE UPDATES, 1999, 2 (02) : 85 - 90

← 1 2 3 4 5 →